Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.2K
Types of Toxins01:36

Types of Toxins

3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
The Apoplast and Symplast01:46

The Apoplast and Symplast

54.3K
Plant growth depends on its ability to take up water and dissolved minerals from the soil. The root system of every plant is equipped with the necessary tissues to facilitate the entry of water and solutes. The plant tissues involved in the transport of water and minerals have two major compartments - the apoplast and the symplast. The apoplast includes everything outside the plasma membrane of living cells and consists of cell walls, extracellular spaces, xylem, phloem, and tracheids. The...
54.3K
Base Excision Repair01:54

Base Excision Repair

26.5K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
26.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Public knowledge and perceptions of kidney transplantation in Singapore: findings from a pilot survey.

Singapore medical journal·2026
Same author

An evidence-based review by the EAU Endourology on standard practices and future directions for ureteral stents in transplant patients.

World journal of urology·2026
Same author

Ureteroscopy for renal allograft lithiasis: institutional experience and global insights from a systematic review.

Translational andrology and urology·2026
Same author

Intravenous immunoglobulin and mammalian target of rapamycin inhibitors for treatment of BK virus infections in kidney transplantation: a systematic review.

Clinical transplantation and research·2025
Same author

Machine Vision Augmentation to Detect Detrusor Overactivity in Overactive Bladder: A Frontier of Artificial Intelligence Application in Functional Urology-Proof of Concept Clinical Study.

Neurourology and urodynamics·2025
Same author

Current Applications and Developments of Natural Language Processing in Kidney Transplantation: A Scoping Review.

Transplantation proceedings·2025

Related Experiment Video

Updated: Feb 15, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.8K

Botulinum toxin and benign prostatic hyperplasia.

Lay Guat Ng1

  • 1Department of Urology, Singapore General Hospital, Singapore.

Asian Journal of Urology
|January 31, 2018
PubMed
Summary
This summary is machine-generated.

Botulinum toxin may still be a viable treatment for benign prostatic hyperplasia (BPH), despite earlier trials suggesting equivalence to placebo. Recent data indicates sustained benefits, warranting further investigation into its therapeutic role for BPH.

Keywords:
Benign prostatic hyperplasiaBladder outlet obstructionBotulinum toxin

More Related Videos

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

26.2K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.7K

Related Experiment Videos

Last Updated: Feb 15, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.8K
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

26.2K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.7K

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Benign prostatic hyperplasia (BPH) causes lower urinary tract symptoms due to prostate enlargement and bladder outlet obstruction.
  • Botulinum toxin has been explored for BPH since 2003, but its efficacy is debated.
  • Two large randomized controlled trials (RCTs) reported results comparable to placebo, diminishing interest.

Purpose of the Study:

  • To re-evaluate the potential therapeutic role of botulinum toxin in managing benign prostatic hyperplasia.
  • To investigate the sustained efficacy of botulinum toxin for BPH symptoms.
  • To reconcile conflicting findings from previous clinical trials and animal studies.

Main Methods:

  • Review of existing randomized controlled trials (RCTs) on botulinum toxin for BPH.
  • Analysis of animal studies investigating botulinum toxin's mechanism in BPH.
  • Evaluation of recent long-term follow-up data from BPH treatment studies.

Main Results:

  • Previous RCTs showed no significant difference between botulinum toxin and placebo.
  • Animal studies and unexplained placebo effects in RCTs suggest a potential biological mechanism.
  • Recent data indicates sustained symptom relief for up to 18 months post-treatment.

Conclusions:

  • The therapeutic value of botulinum toxin for benign prostatic hyperplasia requires further consideration.
  • Despite initial trial outcomes, sustained efficacy and mechanistic insights suggest a potential role.
  • Botulinum toxin may still hold a place in the BPH treatment landscape.